InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,487.03
(
0.25%
)
US TECH 100
19,430.40
(
0.14%
)
Dow Jones
38,834.86
(
0.15%
)
Brent Oil
84.70
(
-0.11%
)
Bitcoin
64,956.64
(
-0.28%
)
Post# of 252255
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

jq1234

Send PM Follow Ignore
Followers 68
Posts 4505
Boards Moderated 0
Alias Born 12/13/2009

jq1234

Re: genisi post# 142787

Monday, 05/28/2012 7:29:40 PM

Monday, May 28, 2012 7:29:40 PM

Post# of 252255
GSK will present dabrafenib monotherapy in ph3 melanoma result at ASCO as well. Would be interesting to see efficacy relative to Zelboraf. If I remember correctly the earlier efficacy result wasn't as striking as Zelboraf.

http://abstract.asco.org/AbstView_114_96291.html

GSK combo maybe will show how two average TKIs combined together can produce more dramatic result than each on its own. Hopefully there will be more and more TKIs combination trials in the future.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up